Stephen Gould
Plus aucun poste en cours
Fortune : 581 $ au 30/04/2024
Profil
Stephen Gould worked as an Executive Director of Translational Oncology at Genentech, Inc. and as a Senior Director at Curis, Inc. He also served as the Chief Scientific Officer at Atreca, Inc. for a year.
Gould holds a doctorate degree from the University of Connecticut Health Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATRECA, INC. CLASS A
0,02% | 11/04/2024 | 6 757 ( 0,02% ) | 581 $ | 30/04/2024 |
Anciens postes connus de Stephen Gould
| Sociétés | Poste | Fin |
|---|---|---|
| ATRECA, INC. | Directeur Technique/Scientifique/R&D | 31/12/2023 |
| CURIS, INC. | Directeur/Membre du Conseil | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Stephen Gould
| University of Connecticut Health Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ATRECA, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
